pargyline has been researched along with Dyskinesia, Medication-Induced in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0 mg/kg) attenuated, in a dose-response fashion, the induction of stereotyped behavior and hyperactivity by pargyline (0." | 1.26 | Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats. ( Freemark, M; Gillin, JC; Moja, EA; Stoff, DM; Wyatt, RJ, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freemark, M | 1 |
| Stoff, DM | 1 |
| Moja, EA | 1 |
| Gillin, JC | 1 |
| Wyatt, RJ | 1 |
1 other study available for pargyline and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats.
Topics: Animals; Behavior; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induce | 1978 |